Literature DB >> 8703803

A sensitive sandwich ELISA for measuring thrombopoietin in human serum: serum thrombopoietin levels in healthy volunteers and in patients with haemopoietic disorders.

T Tahara1, K Usuki, H Sato, H Ohashi, H Morita, H Tsumura, A Matsumoto, H Miyazaki, A Urabe, T Kato.   

Abstract

A sensitive sandwich enzyme-linked immunosorbent assay (ELISA) has been established to estimate serum thrombopoietin (TPO) concentrations in healthy volunteers and patients with haemopoietic disorders. The ELISA uses a mouse monoclonal antibody (Ab) as the capture Ab and a biotinylated rabbit polyclonal Ab as the detector. The ELISA was reproducible, highly sensitive and specific for human TPO. The coefficients of intra-and inter assay variation were from 3.0% to 4.9% and from 5.9% to 6.1%, respectively. The quantitative limit of the ELISA was 0.09 fmol/ml in serum. The quantitative limit was lower than the normal level. The dose-response curves of serum samples from healthy volunteers and patients with haemopoietic disorders were parallel to the standard curves. The ELISA did not cross-react with a variety of blood components and cytokines to produce false-positive results. The serum TPO concentrations from 29 normal males and 21 females were 0.79 +/- 0.35 and 0.70 +/- 0.26 fmol/ml, respectively. Serum TPO levels in patients with aplastic anaemia (AA), acute lymphocytic leukemia (ALL) and essential thrombocythaemia (ET) were measured using the ELISA. The serum TPO levels in the patients with ET (n = 6, 2.80 +/- 1.55 fmol/ml) were higher than the normal level. The patients with AA (n = 7, 18.53 +/- 12.37 fmol/ml) and ALL (n = 5, 10.36 +/- 5.57 fmol/ml) had significantly higher serum TPO levels than normal individuals. These results indicate that the ELISA specific to TPO should prove useful in measuring the TPO concentration in serum samples.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8703803     DOI: 10.1046/j.1365-2141.1996.d01-1741.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  11 in total

1.  Thrombopoietin in human milk.

Authors:  Kousaku Matsubara; Takashi Kato; Hiroshi Miyazaki
Journal:  Int J Hematol       Date:  2002-01       Impact factor: 2.490

2.  Clinical significance of serum angiocidin levels in hepatocellular carcinoma.

Authors:  Yamini Sabherwal; Vicki L Rothman; Ronnie T P Poon; George P Tuszynski
Journal:  Cancer Lett       Date:  2006-12-22       Impact factor: 8.679

3.  Asn-linked sugar chain structures of recombinant human thrombopoietin produced in Chinese hamster ovary cells.

Authors:  N Inoue; T Watanabe; T Kutsukake; H Saitoh; H Tsumura; H Arai; M Takeuchi
Journal:  Glycoconj J       Date:  1999-11       Impact factor: 2.916

4.  Thrombin cleaves recombinant human thrombopoietin: one of the proteolytic events that generates truncated forms of thrombopoietin.

Authors:  T Kato; A Oda; Y Inagaki; H Ohashi; A Matsumoto; K Ozaki; Y Miyakawa; H Watarai; K Fuju; A Kokubo; T Kadoya; Y Ikeda; H Miyazaki
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

5.  The last intron of the human thrombopoietin gene enhances expression in milk of transgenic mice.

Authors:  Yan Li; Mingqian Zhou; Hongwei Zhou; Yunshan Ning
Journal:  Funct Integr Genomics       Date:  2013-11-28       Impact factor: 3.410

6.  Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma.

Authors:  Shinn-Jang Hwang; Jiing-Chyuan Luo; Chung-Pin Li; Cheng-Wei Chu; Jaw-Ching Wu; Chiung-Ru Lai; Jen-Huei Chiang; Gar-Yang Chau; Wing-Yiu Lui; Chun-Chung Lee; Full-Young Chang; Shou-Dong Lee
Journal:  World J Gastroenterol       Date:  2004-09-01       Impact factor: 5.742

7.  New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents.

Authors:  Ara Metjian; Charles S Abrams
Journal:  Biologics       Date:  2009-12-29

8.  Intron V, not intron I of human thrombopoietin, improves expression in the milk of transgenic mice regulated by goat beta-casein promoter.

Authors:  Yan Li; Hu Hao; Mingqian Zhou; Hongwei Zhou; Jianbin Ye; Lijun Ning; Yunshan Ning
Journal:  Sci Rep       Date:  2015-11-03       Impact factor: 4.379

Review 9.  Emerging Concepts in Immune Thrombocytopenia.

Authors:  Maurice Swinkels; Maaike Rijkers; Jan Voorberg; Gestur Vidarsson; Frank W G Leebeek; A J Gerard Jansen
Journal:  Front Immunol       Date:  2018-04-30       Impact factor: 7.561

10.  Glial Fibrillary Acidic Protein as Biomarker Indicates Purity and Property of Auricular Chondrocytes.

Authors:  Satoru Nishizawa; Sanshiro Kanazawa; Yuko Fujihara; Yukiyo Asawa; Satoru Nagata; Motohiro Harai; Atsuhiko Hikita; Tsuyoshi Takato; Kazuto Hoshi
Journal:  Biores Open Access       Date:  2020-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.